Colon cancer screening

Understanding the purpose of colorectal cancer screenings

A colon cancer screening, also called colorectal screening, is a test that looks for early signs of colon cancer before symptoms appear. Most colon cancers start as polyps, which are noncancerous masses that grow on the inner walls of the colon. Polyps tend to grow slowly. A small percentage of these growths turn into cancer. It usually takes a long time (around 10 years) for a polyp to turn into cancer. Colon cancer screening can detect colon cancer and polyps early, which gives you the best chance at successful treatment.

Colon cancer screening guidelines

Medical experts recommend people at average risk of colon cancer start getting screened at age 45. If colon cancer runs in your family, your doctor may recommend screening earlier or more often.

You may need to be tested earlier or more frequently if you have:

  • Inflammatory bowel disease such as Crohn’s disease or ulcerative colitis 
  • A personal or family history of colon cancer or colorectal polyps 
  • Genetic factors like Lynch syndrome, familial adenomatous polyposis (FAP), or hereditary non-polyposis colorectal cancer

Learn more about colon cancer risks and prevention.

Colon cancer screening tests 

Colorectal screening tests help your doctor find cancer early, when it’s easier to treat and before symptoms show up. While diagnostic tests are used when a patient is showing symptoms and needs a diagnosis, screening tests are intended for healthy patients without symptoms.

Screening for hereditary colon cancer

Some colon cancers are caused by gene mutations that can be passed down in families. If colon cancer runs in your family, your doctor may recommend earlier or more frequent screening tests.

The most common genetic syndromes linked to colon cancer are Lynch syndrome and familial adenomatous polyposis.

We offer in-depth expertise in colon cancer genetics. Penn Medicine’s Gastrointestinal Cancer Genetics Program provides screening services to help you understand your risk for hereditary colon cancer, so you can make informed decisions about your health.

National Cancer Institute Designated Comprehensive Cancer Center badge on top of exterior shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.